References S-Z

SABIT, R., GRIFFITHS, T. L., WATKINS, A. J., EVANS, W., BOLTON, C. E., SHALE, D. J. & LEWIS, K. E. (2008) Predictors of poor attendance at an outpatient pulmonary rehabilitation programme. Respir Med, 102, 819-24.
SAJKOV, D., MCEVOY, R. D., COWIE, R. J., BRADLEY, J. A., ANTIC, R., MORRIS, R. G. & FRITH, P. A. (1993) Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease. Chest, 103, 1354-61.
SAJKOV, D., WANG, T., FRITH, P. A., BUNE, A. J., ALPERS, J. A. & MCEVOY, R. D. (1997) A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. Chest, 111, 1622-30.
SAKAE, T. M., PIZZICHINI, M. M., TEIXEIRA, P. J., SILVA, R. M., TREVISOL, D. J. & PIZZICHINI, E. 2013. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol, 39, 259-71.
SALPETER, S., ORMISTON, T. & SALPETER, E. (2002) Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev, CD002992.
SALPETER, S., ORMISTON, T. & SALPETER, E. (2005) Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003566.
SALPETER, S. R., BUCKLEY, N. S. & SALPETER, E. E. (2006) Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med, 21, 1011-9.
SALPETER, S. R., ORMISTON, T. M. & SALPETER, E. E. 2004. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest, 125, 2309-21.
SAMBROOK, P. N., SEEMAN, E., PHILLIPS, S. R. & EBELING, P. R. (2002) Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust, 176 Suppl, S1-16.
SANTO TOMAS, L. H. (2011) Emphysema and chronic obstructive pulmonary disease in coal miners. Curr Opin Pulm Med, 17, 123-5.
SASAKI, T., NAKAYAMA, K., YASUDA, H., YOSHIDA, M., ASAMURA, T., OHRUI, T., ARAI, H., ARAYA, J., KUWANO, K. & YAMAYA, M. 2009. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc, 57, 1453-7.
SCHANE, R. E., WALTER, L. C., DINNO, A., COVINSKY, K. E. & WOODRUFF, P. G. (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med, 23, 1757-62.
SCHARF, S. M., IQBAL, M., KELLER, C., CRINER, G., LEE, S. & FESSLER, H. E. (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med, 166, 314-22.
SCHNELL, K., WEISS, C. O., LEE, T., KRISHNAN, J. A., LEFF, B., WOLFF, J. L. & BOYD, C. (2012) The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med, 12, 26.
SCHOLS, A. M., BROEKHUIZEN, R., WELING-SCHEEPERS, C. A. & WOUTERS, E. F. (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr, 82, 53-9.
SCHONHOFER, B., WENZEL, M., GEIBEL, M. & KOHLER, D. 1998. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med, 26, 1824-8.
SCHOU, L., OSTERGAARD, B., RASMUSSEN, L. S., RYDAHL-HANSEN, S. & PHANARETH, K. 2012. Cognitive dysfunction in patients with chronic obstructive pulmonary disease–a systematic review. Respir Med, 106, 1071-81.
SCHWARTZ, J. L. (1987) Review and Evaluation of Smoking Cessation Methods: The United States and Canada, 1978-1985 (NIH Publication No.87-2940). Bethesda, MD., National Cancer Institute, National Institutes of Health.
SCIURBA, F. C., ERNST, A., HERTH, F. J., STRANGE, C., CRINER, G. J., MARQUETTE, C. H., KOVITZ, K. L., CHIACCHIERINI, R. P., GOLDIN, J. & MCLENNAN, G. (2010) A randomized study of endobronchial valves for advanced emphysema. N Engl J Med, 363, 1233-44.
SEDENTARY BEHAVIOUR RESEARCH, N. 2012. Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol Nutr Metab, 37, 540-2.
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MACCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L. & WEDZICHA, J. A. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164, 1618-23.
SEEMUNGAL, T. A., WILKINSON, T. M., HURST, J. R., PERERA, W. R., SAPSFORD, R. J. & WEDZICHA, J. A. (2008) Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med, 178, 1139-47.
SEGRELLES CALVO, G., GOMEZ-SUAREZ, C., SORIANO, J. B., ZAMORA, E., GONZALEZ-GAMARRA, A., GONZALEZ-BEJAR, M., JORDAN, A., TADEO, E., SEBASTIAN, A., FERNANDEZ, G. & ANCOCHEA, J. 2014. A home telehealth program for patients with severe COPD: the PROMETE study. Respir Med, 108, 453-62.
SELROOS, O., BORGSTROM, L. & INGELF, J. (2009) Use of dry powder inhalers in acute exacerbations of asthma and COPD. Ther Adv Respir Dis, 3, 81-91.
SENDEROVITZ, T., VESTBO, J., FRANDSEN, J., MALTBAEK, N., NORGAARD, M., NIELSEN, C. & KAMPMANN, J. P. (1999) Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med, 93, 715-8.
SERGINSON, J. G., YANG, I. A., ARMSTRONG, J. G., COOPER, D. M., MATTHIESSON, A. M., MORRISON, S. C., GAIR, J. M., COOPER, B. & ZIMMERMAN, P. V. (2009) Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia. Med J Aust, 191, 549-53.
SHAH, P. L. & HERTH, F. J. 2014. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax, 69, 280-6.
SHAH, P. L., ZOUMOT, Z., SINGH, S., BICKNELL, S. R., ROSS, E. T., QUIRING, J., HOPKINSON, N. S., KEMP, S. V. & GROUP, R. T. S. 2013. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med, 1, 233-40.
SHANMUGAM, G., BHUTANI, S., KHAN, D. A. & BROWN, E. S. (2007) Psychiatric considerations in pulmonary disease. Psychiatr Clin North Am, 30, 761-80.
SHARAFKHANEH, A., SOUTHARD, J. G., GOLDMAN, M., URYNIAK, T. & MARTIN, U. J. (2013) Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. Respir Med, 106, 257-68.
SHEPPERD, S., HARWOOD, D., JENKINSON, C., GRAY, A., VESSEY, M. & MORGAN, P. (1998) Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes. BMJ, 316, 1786-91.
SHIFFMAN, S. 2005. Nicotine lozenge efficacy in light smokers. Drug Alcohol Depend, 77, 311-4.
SHIFFMAN, S. & FERGUSON, S. G. 2008. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction, 103, 557-63.
SHIRTCLIFFE, P., MARSH, S., TRAVERS, J., WEATHERALL, M. & BEASLEY, R. (2012) Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J, 42, 83-88.
SHIRTCLIFFE, P., WEATHERALL, M., MARSH, S., TRAVERS, J., HANSELL, A., MCNAUGHTON, A., ALDINGTON, S., MUELLEROVA, H. & BEASLEY, R. (2007) COPD prevalence in a random population survey: a matter of definition. European Respiratory Journal, 30, 232-239.
SHORR, A. F., DOYLE, J., STERN, L., DOLGITSER, M. & ZILBERBERG, M. D. 2008. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin, 24, 1123-30.
SHORR, A. F., SUN, X., JOHANNES, R. S., YAITANES, A. & TABAK, Y. P. (2011) Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest, 140, 1177-83.
SIAFAKAS NM & BOUROS D (1998) Management of acute exacerbation of chronic obstructive pulmonary disease. IN POSTMA, D. & SIAFAKAS NM (Eds.) Management of Chronic Obstructive Pulmonary Disease. Sheffield, ERS Monograph.
SIAFAKAS, N. M., VERMEIRE, P., PRIDE, N. B., PAOLETTI, P., GIBSON, J., HOWARD, P., YERNAULT, J. C., DECRAMER, M., HIGENBOTTAM, T., POSTMA, D. S. & ET AL. (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J, 8, 1398-420.
SIMBERKOFF, M. S., CROSS, A. P., AL-IBRAHIM, M., BALTCH, A. L., GEISELER, P. J., NADLER, J., RICHMOND, A. S., SMITH, R. P., SCHIFFMAN, G., SHEPARD, D. S. & ET AL. (1986) Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med, 315, 1318-27.
SIMONNEAU, G., ROBBINS, I. M., BEGHETTI, M., CHANNICK, R. N., DELCROIX, M., DENTON, C. P., ELLIOTT, C. G., GAINE, S. P., GLADWIN, M. T., JING, Z. C., KROWKA, M. J., LANGLEBEN, D., NAKANISHI, N. & SOUZA, R. (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol, 54, S43-54.
SIN, D. D., BELL, N. R., SVENSON, L. W. & MAN, S. F. (2002) The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med, 112, 120-5.
SINCLAIR, H. K., BOND, C. M. & STEAD, L. F. 2004. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev, CD003698.
SINGH, B., MIELKE, M. M., PARSAIK, A. K., CHA, R. H., ROBERTS, R. O., SCANLON, P. D., GEDA, Y. E., CHRISTIANSON, T. J., PANKRATZ, V. S. & PETERSEN, R. C. 2014a. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol, 71, 581-8.
SINGH, D., JONES, P. W., BATEMAN, E. D., KORN, S., SERRA, C., MOLINS, E., CARACTA, C., GIL, E. G. & LESELBAUM, A. 2014b. Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulm Med, 14, 178.
SINGH, D., PAPI, A., CORRADI, M., PAVLISOVA, I., MONTAGNA, I., FRANCISCO, C., COHUET, G., VEZZOLI, S., SCURI, M. & VESTBO, J. 2016a. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet, 388, 963-73.
SINGH, G., ZHANG, W., KUO, Y. F. & SHARMA, G. 2016. Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD. Chest, 149, 905-15.
SINGH, S., LOKE, Y. K., ENRIGHT, P. & FURBERG, C. D. (2013) Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax, 68, 114-6.
SINGH, S., LOKE, Y. K. & FURBERG, C. D. (2008) Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Jama, 300, 1439-50.
SINGH, S. J., PUHAN, M. A., ANDRIANOPOULOS, V., HERNANDES, N. A., MITCHELL, K. E., HILL, C. J., LEE, A. L., CAMILLO, C. A., TROOSTERS, T., SPRUIT, M. A., CARLIN, B. W., WANGER, J., PEPIN, V., SAEY, D., PITTA, F., KAMINSKY, D. A., MCCORMACK, M. C., MACINTYRE, N., CULVER, B. H., SCIURBA, F. C., REVILL, S. M., DELAFOSSE, V. & HOLLAND, A. E. 2014c. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J, 44, 1447-78.
SKWARSKA, E., COHEN, G., SKWARSKI, K. M., LAMB, C., BUSHELL, D., PARKER, S. & MACNEE, W. (2000) Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax, 55, 907-12.
SLATORE, C. G., BRYSON, C. L. & AU, D. H. (2009) The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med, 122, 472-8.
SMITH, C. B., KANNER, R. E., GOLDEN, C. A., KLAUBER, M. R. & RENZETTI, A. D., JR. (1980) Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis, 141, 271-80.
SMOLLER, J. W., POLLACK, M. H., OTTO, M. W., ROSENBAUM, J. F. & KRADIN, R. L. (1996) Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med, 154, 6-17.
SOLER, N., TORRES, A., EWIG, S., GONZALEZ, J., CELIS, R., EL-EBIARY, M., HERNANDEZ, C. & RODRIGUEZ-ROISIN, R. (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med, 157, 1498-505.
SOLTANI, A., REID, D., WILLS, K. & WALTERS, E. H. 2015. Prospective outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease presenting to hospital: a generalisable clinical audit. Intern Med J, 45, 925-33.
SOURK, R. L. & NUGENT, K. M. (1983) Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis, 128, 153-7.
SPENCER, S., KARNER, C., CATES, C. J. & EVANS, D. J. (2011) Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD007033.
SPRENKLE, M. D., NIEWOEHNER, D. E., MACDONALD, R., RUTKS, I. & WILT, T. J. (2004) Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease, 2, 167 – 175.
SPRUIT, M. A., SINGH, S. J., GARVEY, C., ZUWALLACK, R., NICI, L., ROCHESTER, C., HILL, K., HOLLAND, A. E., LAREAU, S. C., MAN, W. D., PITTA, F., SEWELL, L., RASKIN, J., BOURBEAU, J., CROUCH, R., FRANSSEN, F. M., CASABURI, R., VERCOULEN, J. H., VOGIATZIS, I., GOSSELINK, R., CLINI, E. M., EFFING, T. W., MALTAIS, F., VAN DER PALEN, J., TROOSTERS, T., JANSSEN, D. J., COLLINS, E., GARCIA-AYMERICH, J., BROOKS, D., FAHY, B. F., PUHAN, M. A., HOOGENDOORN, M., GARROD, R., SCHOLS, A. M., CARLIN, B., BENZO, R., MEEK, P., MORGAN, M., RUTTEN-VAN MOLKEN, M. P., RIES, A. L., MAKE, B., GOLDSTEIN, R. S., DOWSON, C. A., BROZEK, J. L., DONNER, C. F. & WOUTERS, E. F. (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 188, e13-64.
SRIDHAR MK, L. M. (2006) Nutritional consequences of disease. Medicine, 34, 530-532.
SRIRAM, K. B. & PERCIVAL, M. 2016. Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients. Chron Respir Dis, 13, 13-22.
STAPLETON, R. D., NIELSEN, E. L., ENGELBERG, R. A., PATRICK, D. L. & CURTIS, J. R. (2005) Association of depression and life-sustaining treatment preferences in patients with COPD. Chest, 127, 328-34.
STEAD, L. F., BUITRAGO, D., PRECIADO, N., SANCHEZ, G., HARTMANN-BOYCE, J. & LANCASTER, T. 2013a. Physician advice for smoking cessation. Cochrane Database Syst Rev, 5, CD000165.
STEAD, L. F., HARTMANN-BOYCE, J., PERERA, R. & LANCASTER, T. 2013b. Telephone counselling for smoking cessation. Cochrane Database Syst Rev, 8, CD002850.
STEAD, L. F. & LANCASTER, T. 2005. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev, CD001007.
STEAD, L. F., PERERA, R., BULLEN, C., MANT, D., HARTMANN-BOYCE, J., CAHILL, K. & LANCASTER, T. 2012. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 11, CD000146.
STEAD, L. F., PERERA, R., BULLEN, C., MANT, D. & LANCASTER, T. (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, CD000146.
STEER, J., NORMAN, E. M., AFOLABI, O. A., GIBSON, G. J. & BOURKE, S. C. (2012) Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax, 67, 117-21.
STEPHENSON, A., SEITZ, D., BELL, C. M., GRUNEIR, A., GERSHON, A. S., AUSTIN, P. C., FU, L., ANDERSON, G. M., ROCHON, P. A. & GILL, S. S. (2011) Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. Arch Intern Med, 171, 914-20.
STOCKLEY, R. A., O’BRIEN, C., PYE, A. & HILL, S. L. (2000) Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest, 117, 1638-45.
STOLZ, D., RASCH, H., LINKA, A., DI VALENTINO, M., MEYER, A., BRUTSCHE, M. & TAMM, M. (2008) A randomised, controlled trial of bosentan in severe COPD. Eur Respir J, 32, 619-28.
STONE, I. S., BARNES, N. C., JAMES, W. Y., MIDWINTER, D., BOUBERTAKH, R., FOLLOWS, R., JOHN, L. & PETERSEN, S. E. 2016. Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med, 193, 717-26
STRUIK, F. M., LACASSE, Y., GOLDSTEIN, R., KERSTJENS, H. M. & WIJKSTRA, P. J. (2013) Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6, CD002878.
STRUIK, F. M., LACASSE, Y., GOLDSTEIN, R. S., KERSTJENS, H. A. & WIJKSTRA, P. J. 2014. Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis. Respir Med, 108, 329-37.
SUGAWARA, K., TAKAHASHI, H., KASAI, C., KIYOKAWA, N., WATANABE, T., FUJII, S., KASHIWAGURA, T., HONMA, M., SATAKE, M. & SHIOYA, T. (2010) Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med, 104, 1883-9.
SUISSA, S., COULOMBE, J. & ERNST, P. 2015. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia. Chest, 148, 1177-83.
SUSANTO, C. & THOMAS, P. S. 2015. Assessing the use of initial oxygen therapy in chronic obstructive pulmonary disease patients: a retrospective audit of pre-hospital and hospital emergency management. Intern Med J, 45, 510-6.
SUZUKI, M., MURO, S., ANDO, Y., OMORI, T., SHIOTA, T., ENDO, K., SATO, S., AIHARA, K., MATSUMOTO, M., SUZUKI, S., ITOTANI, R., ISHITOKO, M., HARA, Y., TAKEMURA, M., UEDA, T., KAGIOKA, H., HIRABAYASHI, M., FUKUI, M. & MISHIMA, M. (2012) A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med, 172, 878-86.
SWANNEY, M. P., RUPPEL, G., ENRIGHT, P. L., PEDERSEN, O. F., CRAPO, R. O., MILLER, M. R., JENSEN, R. L., FALASCHETTI, E., SCHOUTEN, J. P., HANKINSON, J. L., STOCKS, J. & QUANJER, P. H. 2008. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax, 63, 1046-51.
TABAK, Y. P., SUN, X., JOHANNES, R. S., GUPTA, V. & SHORR, A. F. (2009) Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med, 169, 1595-602.
TAN, W. C., VOLLMER, W. M., LAMPRECHT, B., MANNINO, D. M., JITHOO, A., NIZANKOWSKA-MOGILNICKA, E., MEJZA, F., GISLASON, T., BURNEY, P. G. & BUIST, A. S. (2012) Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax, 67, 718-26.
TANG, C. Y., TAYLOR, N. F. & BLACKSTOCK, F. C. (2010) Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy, 96, 1-13.
TANG, C. Y., TAYLOR, N. F., MCDONALD, C. F. & BLACKSTOCK, F. C. 2014. Level of adherence to the GOLD strategy document for management of patients admitted to hospital with an acute exacerbation of COPD. Respirology, 19, 1191-7.
TARPY, S. P. & CELLI, B. R. (1995) Long-term oxygen therapy. N Engl J Med, 333, 710-4.
TASHKIN, D. P., ALTOSE, M. D., CONNETT, J. E., KANNER, R. E., LEE, W. W. & WISE, R. A. (1996) Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med, 153, 1802-11.
TASHKIN, D. P., CELLI, B., SENN, S., BURKHART, D., KESTEN, S., MENJOGE, S. & DECRAMER, M. (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med, 359, 1543-54.
TASHKIN, D. P., LI, N., HALPIN, D., KLEERUP, E., DECRAMER, M., CELLI, B. & ELASHOFF, R. 2013. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Respir Med, 107, 1904-11.
TASHKIN, D. P., RENNARD, S., HAYS, J. T., MA, W., LAWRENCE, D. & LEE, T. C. (2011a) Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest, 139, 591-9.
TASHKIN, D. P., RENNARD, S., TAYLOR HAYS, J., LAWRENCE, D., MARTON, J. P. & LEE, T. C. (2011b) Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med, 105, 1682-90.
TAYLOR, D. R., BUICK, B., KINNEY, C., LOWRY, R. C. & MCDEVITT, D. G. (1985) The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis, 131, 747-51.
TEO, E., HOUSE, H., LOCKHART, K., PURCHURI, S. N., PUSHPARAJAH, J., CRIPPS, A. W. & VAN DRIEL, M. L. 2014. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD010010.
TERADA, K., MURO, S., OHARA, T., KUDO, M., OGAWA, E., HOSHINO, Y., HIRAI, T., NIIMI, A., CHIN, K. & MISHIMA, M. 2010. Abnormal swallowing reflex and COPD exacerbations. Chest, 137, 326-32.
TERADA, K., MURO, S., SATO, S., OHARA, T., HARUNA, A., MARUMO, S., KINOSE, D., OGAWA, E., HOSHINO, Y., NIIMI, A., TERADA, T. & MISHIMA, M. (2008) Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax, 63, 951-5.
THAON, I., THIEBAUT, A., JOCHAULT, L., LEFEBVRE, A., LAPLANTE, J. J. & DALPHIN, J. C. (2011) Influence of hay and animal feed exposure on respiratory status: a longitudinal study. Eur Respir J, 37, 767-74.
THERAPEUTIC GUIDELINES LIMITED 2014. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited,
THOMPSON, A. B., MUELLER, M. B., HEIRES, A. J., BOHLING, T. L., DAUGHTON, D., YANCEY, S. W., SYKES, R. S. & RENNARD, S. I. (1992) Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis, 146, 389-95.
THORP, A. A., OWEN, N., NEUHAUS, M. & DUNSTAN, D. W. 2011. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med, 41, 207-15.
TOBACCO USE AND DEPENDENCE GUIDELINE PANEL 2008. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care, 53, 1217-22.

TOELLE, B. G., XUAN, W., BIRD, T. E., ABRAMSON, M. J., ATKINSON, D. N., BURTON, D. L., JAMES, A. L., JENKINS, C. R., JOHNS, D. P., MAGUIRE, G. P., MUSK, A. W., WALTERS, E. H., WOOD-BAKER, R., HUNTER, M. L., GRAHAM, B. J., SOUTHWELL, P. J., VOLLMER, W. M., BUIST, A. S., & MARKS, G. B. (2013) Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust, 198, 144-8.
TOMMELEIN, E., MEHUYS, E., VAN HEES, T., ADRIAENS, E., VAN BORTEL, L., CHRISTIAENS, T., VAN TONGELEN, I., REMON, J. P., BOUSSERY, K. & BRUSSELLE, G. 2014. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol, 77, 756-66.
TONNESEN, P., CARROZZI, L., FAGERSTROM, K. O., GRATZIOU, C., JIMENEZ-RUIZ, C., NARDINI, S., VIEGI, G., LAZZARO, C., CAMPELL, I. A., DAGLI, E. & WEST, R. (2007) Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J, 29, 390-417.
TRAPPENBURG, J. C., MONNINKHOF, E. M., BOURBEAU, J., TROOSTERS, T., SCHRIJVERS, A. J., VERHEIJ, T. J. & LAMMERS, J. W. (2011) Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax, 66, 977-84.
TRIVEDI, R., RICHARD, N., MEHTA, R. & CHURCH, A. 2014. Umeclidinium in patients with COPD: a randomised, placebo-controlled study. Eur Respir J, 43, 72-81.
TROOSTERS, T., SCIURBA, F. C., DECRAMER, M., SIAFAKAS, N. M., KLIOZE, S. S., SUTRADHAR, S. C., WEISMAN, I. M. & YUNIS, C. 2014. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. NPJ Prim Care Respir Med, 24, 14003.
TSAI, L. L., ALISON, J. A., MCKENZIE, D. K. & MCKEOUGH, Z. J. 2016. Physical activity levels improve following discharge in people admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease. Chron Respir Dis, 13, 23-32.
TSE, H. N., RAITERI, L., WONG, K. Y., YEE, K. S., NG, L. Y., WAI, K. Y., LOO, C. K. & CHAN, M. H. 2013. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest, 144, 106-18.
TURNER, S. E., EASTWOOD, P. R., CECINS, N. M., HILLMAN, D. R. & JENKINS, S. C. (2004) Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest, 126, 766-73.
U. S. PREVENTIVE SERVICES TASK FORCE, SIU, A. L., BIBBINS-DOMINGO, K., GROSSMAN, D. C., DAVIDSON, K. W., EPLING, J. W., JR., GARCIA, F. A., GILLMAN, M., KEMPER, A. R., KRIST, A. H., KURTH, A. E., LANDEFELD, C. S., MANGIONE, C. M., HARPER, D. M., PHILLIPS, W. R., PHIPPS, M. G. & PIGNONE, M. P. 2016. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA, 315, 1372-7
UCHIDA, H., SUZUKI, T., MAMO, D. C., MULSANT, B. H., KIKUCHI, T., TAKEUCHI, H., TOMITA, M., WATANABE, K., YAGI, G. & KASHIMA, H. (2009) Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. J Anxiety Disord, 23, 477-81.
UKAWA, S., TAMAKOSHI, A., YATSUYA, H., YAMAGISHI, K., ANDO, M. & ISO, H. 2015. Association Between Average Daily Television Viewing Time and Chronic Obstructive Pulmonary Disease-Related Mortality: Findings From the Japan Collaborative Cohort Study. J Epidemiol, 25, 431-6.
ULRIK, C. S. 2014. Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis, 9, 331-8.
US PUBLIC HEALTH SERVICE (2000) A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA, 283, 3244-54.
UZUN, S., DJAMIN, R. S., KLUYTMANS, J. A., MULDER, P. G., VAN’T VEER, N. E., ERMENS, A. A., PELLE, A. J., HOOGSTEDEN, H. C., AERTS, J. G. & VAN DER EERDEN, M. M. 2014. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med, 2, 361-8.
VAN BOVEN, J. F., CHAVANNES, N. H., VAN DER MOLEN, T., RUTTEN-VAN MOLKEN, M. P., POSTMA, M. J. & VEGTER, S. 2014. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med, 108, 103-13.
VAN DER PALEN, J., GINKO, T., KROKER, A., VAN DER VALK, P., GOOSENS, M., PADULLES, L., SEOANE, B., REKEDA, L. & GARCIA GIL, E. (2013) Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv, 10, 1023-31.
VAN DIJK, W. D., GUPTA, N., TAN, W. C. & BOURBEAU, J. 2014. Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD, 11, 113-20.
VAN EERD, E. A., VAN DER MEER, R. M., VAN SCHAYCK, O. C. & KOTZ, D. 2016. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, Cd010744.
VAN GEFFEN, W. H., DOUMA, W. R., SLEBOS, D. J. & KERSTJENS, H. A. 2016. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. Cochrane Database Syst Rev, Cd011826.
VAN GESTEL, Y. R., HOEKS, S. E., SIN, D. D., STAM, H., MERTENS, F. W., BAX, J. J., VAN DOMBURG, R. T. & POLDERMANS, D. 2009. Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD. Int J Chron Obstruct Pulmon Dis, 4, 177-83.
VANFLETEREN, L. E., FRANSSEN, F. M., USZKO-LENCER, N. H., SPRUIT, M. A., CELIS, M., GORGELS, A. P. & WOUTERS, E. F. (2011) Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am J Cardiol, 108, 1669-74.
VARRASO, R., CHIUVE, S. E., FUNG, T. T., BARR, R. G., HU, F. B., WILLETT, W. C. & CAMARGO, C. A. 2015. Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study. BMJ, 350, h286.
VARRASO, R., FUNG, T. T., BARR, R. G., HU, F. B., WILLETT, W. & CAMARGO, C. A. J. 2007a. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr, 86, 488ā€“495.
VARRASO, R., FUNG, T. T., HU, F. B., WILLETT, W. & CAMARGO, C. A. 2007b. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax, 62, 786-91.
VATHENEN, A. S., BRITTON, J. R., EBDEN, P., COOKSON, J. B., WHARRAD, H. J. & TATTERSFIELD, A. E. (1988) High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis, 138, 850-5.
VESTBO, J., ANDERSON, J. A., BROOK, R. D., CALVERLEY, P. M., CELLI, B. R., CRIM, C., MARTINEZ, F., YATES, J., NEWBY, D. E. & INVESTIGATORS, S. 2016. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet, 387, 1817-26.
VESTBO, J., ANDERSON, J. A., CALVERLEY, P. M., CELLI, B., FERGUSON, G. T., JENKINS, C., KNOBIL, K., WILLITS, L. R., YATES, J. C. & JONES, P. W. (2009) Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939-43.
VESTBO, J., PRESCOTT, E., ALMDAL, T., DAHL, M., NORDESTGAARD, B. G., ANDERSEN, T., SORENSEN, T. I. & LANGE, P. (2006) Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med, 173, 79-83.
VESTBO, J., SORENSEN, T., LANGE, P., BRIX, A., TORRE, P. & VISKUM, K. (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 353, 1819-23.
VIVODTZEV, I., TAMISIER, R., BAGUET, J. P., BOREL, J. C., LEVY, P. & PEPIN, J. L. 2014. Arterial stiffness in COPD. Chest, 145, 861-75.
VOGELMEIER, C., HEDERER, B., GLAAB, T., SCHMIDT, H., RUTTEN-VAN MOLKEN, M. P., BEEH, K. M., RABE, K. F. & FABBRI, L. M. (2011) Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med, 364, 1093-1103.
VOGELMEIER, C. F., BATEMAN, E. D., PALLANTE, J., ALAGAPPAN, V. K., D’ANDREA, P., CHEN, H. & BANERJI, D. 2013. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study. Lancet Respir Med, 1, 51-60.
VOLLENWEIDER, D. J., JARRETT, H., STEURER-STEY, C. A., GARCIA-AYMERICH, J. & PUHAN, M. A. 2012. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, CD010257.
VOLLMER, W. M., GISLASON, T., BURNEY, P., ENRIGHT, P. L., GULSVIK, A., KOCABAS, A. & BUIST, A. S. 2009. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J, 34, 588-97.
VONBANK, K., ZIESCHE, R., HIGENBOTTAM, T. W., STIEBELLEHNER, L., PETKOV, V., SCHENK, P., GERMANN, P. & BLOCK, L. H. (2003) Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax, 58, 289-93.
VORRINK, S. N., KORT, H. S., TROOSTERS, T. & LAMMERS, J. W. 2011. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res, 12, 33.
VOZORIS, N. T., FISCHER, H. D., WANG, X., STEPHENSON, A. L., GERSHON, A. S., GRUNEIR, A., AUSTIN, P. C., ANDERSON, G. M., BELL, C. M., GILL, S. S. & ROCHON, P. A. 2014. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J, 44, 332-40.
WAGNER, E. H., AUSTIN, B. T. & VON KORFF, M. (1996) Organizing care for patients with chronic illness. Milbank Q, 74, 511-44.
WAKABAYASHI, K., GONZALEZ, M. A., DELHAYE, C., BEN-DOR, I., MALUENDA, G., COLLINS, S. D., SYED, A. I., GAGLIA, M. A., JR., TORGUSON, R., XUE, Z., SUDDATH, W. O., SATLER, L. F., KENT, K. M., LINDSAY, J., PICHARD, A. D. & WAKSMAN, R. (2010) Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol, 106, 305-9.
WALSH, E. E., FALSEY, A. R. & HENNESSEY, P. A. (1999) Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med, 160, 791-5.
WALTERS, J. A., SMITH, S., POOLE, P., GRANGER, R. H. & WOOD-BAKER, R. (2011a) Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD001390.
WALTERS, J. A., TAN, D. J., WHITE, C. J., GIBSON, P. G., WOOD-BAKER, R. & WALTERS, E. H. 2014a. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD001288.
WALTERS, J. A., TAN, D. J., WHITE, C. J. & WOOD-BAKER, R. 2014b. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, CD006897.
WALTERS, J. A., TURNOCK, A. C., WALTERS, E. H. & WOOD-BAKER, R. (2010) Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD005074.
WALTERS, J. A., WALTERS, E. H., NELSON, M., ROBINSON, A., SCOTT, J., TURNER, P. & WOOD-BAKER, R. (2011b) Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J, 20, 396-402.
WANG, J. X., ZHANG, S. M., LI, X. H., ZHANG, Y., XU, Z. Y. & CAO, B. 2016. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Int J Infect Dis, 48, 40-5.
WASCHKI, B., KIRSTEN, A. M., HOLZ, O., MUELLER, K. C., SCHAPER, M., SACK, A. L., MEYER, T., RABE, K. F., MAGNUSSEN, H. & WATZ, H. 2015. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 192, 295-306.
WATZ, H., PITTA, F., ROCHESTER, C. L., GARCIA-AYMERICH, J., ZUWALLACK, R., TROOSTERS, T., VAES, A. W., PUHAN, M. A., JEHN, M., POLKEY, M. I., VOGIATZIS, I., CLINI, E. M., TOTH, M., GIMENO-SANTOS, E., WASCHKI, B., ESTEBAN, C., HAYOT, M., CASABURI, R., PORSZASZ, J., MCAULEY, E., SINGH, S. J., LANGER, D., WOUTERS, E. F., MAGNUSSEN, H. & SPRUIT, M. A. 2014. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J, 44, 1521-37.
WEDZICHA, J. A., BANERJI, D., CHAPMAN, K. R., VESTBO, J., ROCHE, N., AYERS, R. T., THACH, C., FOGEL, R., PATALANO, F., VOGELMEIER, C. F. & INVESTIGATORS, F. 2016. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. N Engl J Med, 374, 2222-34.
WEDZICHA, J. A., CALVERLEY, P. M., SEEMUNGAL, T. A., HAGAN, G., ANSARI, Z. & STOCKLEY, R. A. (2008) The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med, 177, 19-26.
WEDZICHA, J. A., DECRAMER, M., FICKER, J. H., NIEWOEHNER, D. E., SANDSTROM, T., TAYLOR, A. F., D’ANDREA, P., ARRASATE, C., CHEN, H. & BANERJI, D. 2013. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med, 1, 199-209.
WEILL, D., BENDEN, C., CORRIS, P. A., DARK, J. H., DAVIS, R. D., KESHAVJEE, S., LEDERER, D. J., MULLIGAN, M. J., PATTERSON, G. A., SINGER, L. G., SNELL, G. I., VERLEDEN, G. M., ZAMORA, M. R. & GLANVILLE, A. R. 2015. A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 34, 1-15.
WEITZENBLUM, E., SAUTEGEAU, A., EHRHART, M., MAMMOSSER, M. & PELLETIER, A. (1985) Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 131, 493-8.
WELLS, J. M., WASHKO, G. R., HAN, M. K., ABBAS, N., NATH, H., MAMARY, A. J., REGAN, E., BAILEY, W. C., MARTINEZ, F. J., WESTFALL, E., BEATY, T. H., CURRAN-EVERETT, D., CURTIS, J. L., HOKANSON, J. E., LYNCH, D. A., MAKE, B. J., CRAPO, J. D., SILVERMAN, E. K., BOWLER, R. P. & DRANSFIELD, M. T. (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med, 367, 913-21.
WELSH, E. J., CATES, C. J. & POOLE, P. (2013) Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 5, CD007891
WHITTAKER, R., MCROBBIE, H., BULLEN, C., BORLAND, R., RODGERS, A. & GU, Y. 2012. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev, 11, CD006611.
WHITTERS, D. & STOCKLEY, R. A. 2013. Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management. Drugs Aging, 30, 215-25.
WILDMAN, M. J., SANDERSON, C. F., GROVES, J., REEVES, B. C., AYRES, J. G., HARRISON, D., YOUNG, D. & ROWAN, K. (2009) Survival and quality of life for patients with COPD or asthma admitted to intensive care in a UK multicentre cohort: the COPD and Asthma Outcome Study (CAOS). Thorax, 64, 128-32.
WILKINSON, T. M., DONALDSON, G. C., HURST, J. R., SEEMUNGAL, T. A. & WEDZICHA, J. A. (2004) Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 169, 1298-303.
WILLIAMS, J. E., GREEN, R. H., WARRINGTON, V., STEINER, M. C., MORGAN, M. D. & SINGH, S. J., (2012) Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. Respir Med, 106, 390-6.
WILLIAMS, J. H., JR. & MOSER, K. M. (1986) Pneumococcal vaccine and patients with chronic lung disease. Ann Intern Med, 104, 106-9.
WILSON, R. (1998) The role of infection in COPD. Chest, 113, 242S-248S.
WILT, T. J., NIEWOEHNER, D., KIM, C., KANE, R. L., LINABERY, A., TACKLIND, J., MACDONALD, R. & RUTKS, I. (2005) Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evid Rep Technol Assess (Summ), 1-7.
WISE, R. A., ANZUETO, A., COTTON, D., DAHL, R., DEVINS, T., DISSE, B., DUSSER, D., JOSEPH, E., KATTENBECK, S., KOENEN-BERGMANN, M., PLEDGER, G. & CALVERLEY, P. (2013) Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med, 369, 1491-501.
WONG, C. X., CARSON, K. V. & SMITH, B. J. (2012) Home care by outreach nursing for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 4, CD000994.
WOOD, D. E., NADER, D. A., SPRINGMEYER, S. C., ELSTAD, M. R., COXSON, H. O., CHAN, A., RAI, N. S., MULARSKI, R. A., COOPER, C. B., WISE, R. A., JONES, P. W., MEHTA, A. C., GONZALEZ, X. & STERMAN, D. H. 2014. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol, 21, 288-97.
WOOTTON, S. L., NG, L. W., MCKEOUGH, Z. J., JENKINS, S., HILL, K., EASTWOOD, P. R., HILLMAN, D. R., CECINS, N., SPENCER, L. M., JENKINS, C. & ALISON, J. A. 2014. Ground-based walking training improves quality of life and exercise capacity in COPD. Eur Respir J, 44, 885-94.
WORLD HEALTH ORGANIZATION (1999) Tobacco Free Initiative: Policies for Public Health. Geneva, World Health Organization.
WU, T. C., HUANG, Y. C., HSU, S. Y., WANG, Y. C. & YEH, S. L. (2007) Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int J Vitam Nutr Res, 77, 272-9.
XIA, N., WANG, H. & NIE, X. 2015. Inhaled Long-Acting beta2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis. PLoS One, 10, e0137904.
XU, W., COLLET, J. P., SHAPIRO, S., LIN, Y., YANG, T., PLATT, R. W., WANG, C. & BOURBEAU, J. (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med, 178, 913-20.
YANG, I. A., CLARKE, M. S., SIM, E. H. & FONG, K. M. (2012) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 7, CD002991.
YAO, G. Y., MA, Y. L., ZHANG, M. Q. & GAO, Z. C. 2013. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis. Respiration, 86, 254-60.
YELLOWLEES, P. M., ALPERS, J. H., BOWDEN, J. J., BRYANT, G. D. & RUFFIN, R. E. (1987) Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust, 146, 305-7.
YOHANNES, A. M. & ERSHLER, W. B. 2011a. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care, 56, 644-52.
YOHANNES, A. M., RAUE, P. J., KANELLOPOULOS, D., MCGOVERN, A., SIREY, J. A., KIOSSES, D. N., BANERJEE, S., SEIRUP, J. K., NOVITCH, R. S. & ALEXOPOULOS, G. S. 2016. Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital. Chest, 149, 467-73.
YOHANNES, A. M., WILLGOSS, T. G. & VESTBO, J. (2011b) Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care, 56, 477-87.
ZHOU, Y., WANG, X., ZENG, X., QIU, R., XIE, J., LIU, S., ZHENG, J., ZHONG, N. & RAN, P. (2006) Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. Respirology, 11, 603-10.
ZIELINSKI, J., TOBIASZ, M., HAWRYLKIEWICZ, I., SLIWINSKI, P. & PALASIEWICZ, G. (1998) Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest, 113, 65-70.
ZIGMOND, A. & SNAITH, R. (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand, 67, 361-70
ZOUMOT, Z., KEMP, S. V., SINGH, S., BICKNELL, S. R., MCNULTY, W. H., HOPKINSON, N. S., ROSS, E. T. & SHAH, P. L. 2015. Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One, 10, e0122656.
ZWAR, N. A. R., R.; BORLAND, R.; STILLMAN, S.; CUNNINGHAM, M.; LITT, J, 2004. Smoking Cessation Guidelines for Australian General Practice: Practice Handbook, Canberra, Australian Government Department of Health and Ageing; National Tobacco Strategy.
ZWAR, N. A., MARKS, G. B., HERMIZ, O., MIDDLETON, S., COMINO, E. J., HASAN, I., VAGHOLKAR, S. & WILSON, S. F. (2011) Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust, 195, 168-71.
ZWAR, N. A., MENDELSOHN, C. P. & RICHMOND, R. L. 2014. Supporting smoking cessation. BMJ, 348, f7535.
ZWERINK, M., BRUSSE-KEIZER, M., VAN DER VALK, P. D., ZIELHUIS, G. A., MONNINKHOF, E. M., VAN DER PALEN, J., FRITH, P. A. & EFFING, T. 2014. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD002990.
ZWERINK, M., KERSTJENS, H. A., VAN DER PALEN, J., VAN DER VALK, P., BRUSSE-KEIZER, M., ZIELHUIS, G. & EFFING, T. 2016. (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT. Respirology, 21, 497-503.